96 results for “TDS”+ Section 32(1)(ii)clear
Sorted by relevance
Key Topics
Showing 1–20 of 96 · Page 1 of 5
32,04,668/- under the provisions of section 35(2AB) in respect of product development expenditure. However, the prescribed authority i.e. DSIR had only certified that only a sum of Rs.80,48,24,167/- was eligible for weighted deduction u/s 35(2AB) and the DSIR had not certified the expenditure claimed on clinical trial expenses amounting to Rs.4